Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03875365 · ClinicalTrials.gov registry record
Institutional Outcome Data From Per-oral Plication of the Esophagus
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 20
- Enrollment target
NCT03875365: Clinical Trial study, sponsored by Mayo Clinic.
NCT03875365 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03875365 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Researchers are reviewing and analyzing surgical and clinical outcomes of subjects who underwent POPE for end-stage achalasia, a sigmoid esophagus, or a redundant conduit that has been used to replace the esophagus. This data will help researchers determine the safety and efficacy of a novel minimally invasive treatment compared to invasive surgery.
Primary Outcome
Evaluate safety by assessment of adverse events of the novel minimally invasive treatment compared to invasive surgery.
Interventions
- PROCEDURE POPE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-10-02 |
| Est. Completion | 2024-01-19 |
Why NCT03875365 stopped before completion
NCT03875365 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which POPE is the first listed.
NCT03875365 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03875365 about?
NCT03875365 is a clinical study titled "Institutional Outcome Data From Per-oral Plication of the Esophagus". Researchers are reviewing and analyzing surgical and clinical outcomes of subjects who underwent POPE for end-stage achalasia, a sigmoid esophagus, or a redundant conduit that has been used to replace the esophagus. This data will help researchers determine the safety and efficacy of a novel minimal...
What is the current status of trial NCT03875365?
This trial is currently terminated. The enrollment target is 20 participants. The study started on 2018-10-02. Estimated completion is 2024-01-19.
What interventions are being tested in trial NCT03875365?
The interventions under investigation include: POPE (PROCEDURE).
Who is sponsoring clinical trial NCT03875365?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI